Article Information
History
- June 23, 2020.
Article Versions
- Version 1 (May 3, 2020 - 00:06).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Maria Artesi1,#,
- Sébastien Bontems2,#,
- Paul Göbbels3,
- Marc Franckh3,
- Piet Maes4,
- Raphaël Boreux2,
- Cécile Meex2,
- Pierrette Melin2,
- Marie-Pierre Hayette2,§,*,
- Vincent Bours1,5,§,* and
- Keith Durkin1,§,*
- 1Laboratory of Human Genetics, GIGA Research Institute, Liège, Belgium
- 2Department of Clinical Microbiology, University Hospital of Liège, Liège, Belgium
- 3St-Nikolaus Hospital, Eupen, Belgium
- 4Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium
- 5Department of Human Genetics, University Hospital of Liège, Liège, Belgium
- ↵*Correspondence: kdurkin{at}uliege.be; vbours{at}uliege.be; mphayette{at}chuliege.be
↵# These authors contributed equally
Posted June 23, 2020.
A recurrent mutation at position 26,340 of SARS-CoV-2 is associated with failure of the E-gene qRT-PCR utilised in a commercial dual-target diagnostic assay
